688046 藥康生物
按盤價 
17.500 +0.390 (+2.279%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.296 | 5.157 | 7.747 | 11.918 | 17.316 |
| 總資產報酬率 ROA (%) | 2.640 | 4.265 | 6.579 | 9.955 | 12.895 |
| 投入資產回報率 ROIC (%) | 2.817 | 4.597 | 7.128 | 11.022 | 15.361 | 邊際利潤分析 |
| 銷售毛利率 (%) | 64.275 | 61.992 | 67.611 | 71.383 | 74.330 |
| 營業利潤率 (%) | 20.684 | 17.379 | 26.308 | 33.676 | 36.381 |
| 息稅前利潤/營業總收入 (%) | 19.630 | 15.671 | 23.635 | 30.693 | 35.815 |
| 淨利潤/營業總收入 (%) | 18.918 | 15.989 | 25.541 | 31.878 | 31.725 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 113.239 | 89.461 | 84.354 | 71.657 | 72.406 |
| 價值變動淨收益/利潤總額(%) | 2.225 | 8.678 | 8.832 | 5.437 | 7.979 |
| 營業外收支淨額/利潤總額(%) | -0.107 | -0.128 | -1.488 | -0.157 | 0.035 | 償債能力分析 |
| 流動比率 (X) | 3.277 | 4.606 | 4.524 | 6.853 | 3.687 |
| 速動比率 (X) | 3.162 | 4.460 | 4.395 | 6.622 | 3.530 |
| 資產負債率 (%) | 22.533 | 17.022 | 17.572 | 12.247 | 25.491 |
| 帶息債務/全部投入資本 (%) | 13.973 | 8.791 | 6.469 | 2.625 | 5.665 |
| 股東權益/帶息債務 (%) | 591.935 | 1,006.078 | 1,389.316 | 3,596.763 | 1,552.634 |
| 股東權益/負債合計 (%) | 343.797 | 487.471 | 469.088 | 716.557 | 292.300 |
| 利息保障倍數 (X) | -19.023 | -9.292 | -10.332 | -10.472 | -61.858 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 183.940 | 162.536 | 131.518 | 105.860 | 95.648 |
| 存貨周轉天數 (天) | 78.479 | 69.840 | 86.251 | 96.874 | 84.413 |
| 備註： | 即時報價更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
